相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Melatonin Receptor as a Drug Target for Neuroprotection
Pawaris Wongprayoon et al.
CURRENT MOLECULAR PHARMACOLOGY (2021)
Prophylactic administration of carnosine and melatonin abates the incidence of apoptosis, inflammation, and DNA damage induced by titanium dioxide nanoparticles in rat livers
Laila Mohamed Fadda et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2020)
Immunoregulatory role of melatonin in cancer
Fatemeh Moradkhani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Molecular and Biological Functions of Melatonin in Endometrial Cancer
Parisa Maleki Dana et al.
CURRENT DRUG TARGETS (2020)
A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors
Mari C. Vazquez-Borrego et al.
CLINICAL CANCER RESEARCH (2020)
The effects of melatonin supplementation on blood pressure in patients with metabolic disorders: a systematic review and meta-analysis of randomized controlled trials (vol 33, pg 202, 2019)
Maryam Akbari et al.
JOURNAL OF HUMAN HYPERTENSION (2020)
Melatonin: A review of its potential functions and effects on neurological diseases
M. Gunata et al.
REVUE NEUROLOGIQUE (2020)
COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission
Jinyang Gu et al.
GASTROENTEROLOGY (2020)
Evidence for Gastrointestinal Infection of SARS-CoV-2
Fei Xiao et al.
GASTROENTEROLOGY (2020)
Somatostatin Analogs in Clinical Practice: A Review
Mariana Gomes-Porras et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Melatonin MT1 and MT2 receptor ERK signaling is differentially dependent on Gi/o and Gq/11 proteins
Min Chen et al.
JOURNAL OF PINEAL RESEARCH (2020)
The role of melatonin on miRNAs modulation in triple-negative breast cancer cells
Livia C. Ferreira et al.
PLOS ONE (2020)
Ectopic pituitary adenoma of the TSH-secreting sphenoidal sinus with excellent response to somatostatin analogs. Theory of the embryogenesis and literature review from a clinical case
Eugenia Ortiz et al.
STEROIDS (2020)
Expression of Melatonin and Dopamine D3 Receptor Heteromers in Eye Ciliary Body Epithelial Cells and Negative Correlation with Ocular Hypertension
Irene Reyes-Resina et al.
CELLS (2020)
Melatonin attenuates choroidal neovascularization by regulating macrophage/microglia polarization via inhibition of RhoA/ROCK signaling pathway
Yue Xu et al.
JOURNAL OF PINEAL RESEARCH (2020)
Melatonin-triggered post-transcriptional and post-translational modifications of ADAMTS1 coordinately retard tumorigenesis and metastasis of renal cell carcinoma
Yu-Ching Wen et al.
JOURNAL OF PINEAL RESEARCH (2020)
A pan-cancer analysis of the clinical and genetic portraits of somatostatin receptor expressing tumor as a potential target of peptide receptor imaging and therapy
Hyunjong Lee et al.
EJNMMI RESEARCH (2020)
Coronavirus disease 2019 (COVID-19): A literature review
Harapan Harapan et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis
Mehdi Manoochehri et al.
MOLECULAR ONCOLOGY (2020)
Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial
Ahmad Zare Javid et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2020)
Melatonin protects against apoptosis of megakaryocytic cells via its receptors and the AKT/mitochondrial/caspase pathway
Mo Yang et al.
Aging-US (2020)
COVID-19 treatment: Combining anti-inflammatory and antiviral therapeutics using a network-based approach
Feixiong Cheng et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2020)
Somatostatin receptor profile in pituitary thyrotroph adenomas
Eleni Thodou et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2020)
Melatonin: an endogenous miraculous indolamine, fights against cancer progression
Saptadip Samanta
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment
Virna Margarita Martin Gimenez et al.
LIFE SCIENCES (2020)
17β-Estradiol augments the neuroprotective effect of agomelatine in depressive- and anxiety-like behaviors in ovariectomized rats
Yasmine A. El-Khatib et al.
PSYCHOPHARMACOLOGY (2020)
Epidemiology of COVID-19
Cemal Bulut et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2020)
Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
Jiaojiao Hao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Melatonin is a potential inhibitor of ovarian cancer: molecular aspects
Hadis Zare et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy
Victoria Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms
Federico Gatto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1/ROS/VEGF
Jiao Cheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
A Novel Somatostatin-Dopamine Chimera (BIM23B065) Reduced GH Secretion in a First-in-Human Clinical Trial
Wadim M. de Boon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Is There Sufficient Evidence that the Melatonin Binding Site MT3 Is Quinone Reductase 2?
Jean A. Boutin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Evaluation of expression of somatostatin receptor 1, 2, 3, 5 and dopamine D2 receptor in spindle cell oncocytomas of posterior pituitary
Jiri Soukup et al.
PITUITARY (2019)
The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial
Hadi Bazyar et al.
INFLAMMOPHARMACOLOGY (2019)
Somatostatin analog challenge test in the pre-surgical management of ACTH-secreting pheochromocytoma
Alessandro Rossini et al.
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS (2019)
Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study
Jakob Dal et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF-7 human breast cancer cells
Carolina Alonso-Gonzalez et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Melatonin and Cancer Hallmarks
Wamidh H. Talib
MOLECULES (2018)
The Molecular Basis of G Protein-Coupled Receptor Activation
William I. Weis et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 87 (2018)
Divergent Matrix-Remodeling Strategies Distinguish Developmental from Neoplastic Mammary Epithelial Cell Invasion Programs
Tamar Y. Feinberg et al.
DEVELOPMENTAL CELL (2018)
Melatonin Inhibits the Progression of Hepatocellular Carcinoma through MicroRNA Let7i-3p Mediated RAF1 Reduction
Tong-Hong Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
Thomas Guenther et al.
PHARMACOLOGICAL REVIEWS (2018)
Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis
Angelica L. Sanchez-Lopez et al.
ARCHIVES OF MEDICAL RESEARCH (2018)
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
Russel J. Reiter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats
Yohan Ricci Zonta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A 13C Stable Isotope-Resolved Metabolomic Study
David Hevia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma
Shibo Lin et al.
JOURNAL OF PINEAL RESEARCH (2017)
Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence
Nasser Hashemi Goradel et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells
Giuliana Gatti et al.
Oncotarget (2017)
Orphan GPR61, GPR62 and GPR135 receptors and the melatonin MT2 receptor reciprocally modulate their signaling functions
Atsuro Oishi et al.
SCIENTIFIC REPORTS (2017)
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Bryan Oronsky et al.
NEOPLASIA (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Melatonin transport into mitochondria
Juan C. Mayo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Participation of MT3 melatonin receptors in the synergistic effect of melatonin on cytotoxic and apoptotic actions evoked by chemotherapeutics
Roberto Pariente et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Melatonin and the electron transport chain
Ruediger Hardeland
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Role of toll-like receptor 4 in melatonin-induced cardioprotection
Frederic Nduhirabandi et al.
JOURNAL OF PINEAL RESEARCH (2016)
Melatonin suppression of aerobic glycolysis (Warburg effect), survival signalling and metastasis in human leiomyosarcoma
Lulu Mao et al.
JOURNAL OF PINEAL RESEARCH (2016)
Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future
Kjell Oberg et al.
ENDOCRINE-RELATED CANCER (2016)
Effects of melatonin on HIF-1α and VEGF expression and on the invasive properties of hepatocarcinoma cells
Jucimara Colombo et al.
ONCOLOGY LETTERS (2016)
Melatonin Induces Cell Apoptosis in AGS Cells Through the Activation of JNK and P38 MAPK and the Suppression of Nuclear Factor-Kappa B: a Novel Therapeutic Implication for Gastric Cancer
Weimin Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily
Bryan L. Roth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Melatonin influences somatostatin secretion from human pancreatic delta-cells via MT1 and MT2 receptors
Juliane Zibolka et al.
JOURNAL OF PINEAL RESEARCH (2015)
Human somatostatin receptor-3 distinctively induces apoptosis in MCF-7 and cell cycle arrest in MDA-MB-231 breast cancer cells
Sajad A. War et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Therapeutic uses of somatostatin and its analogues: Current view and potential applications
Uma Rai et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: Effect of mono- and bi-specific somatostatin analogs on cell growth
M. Ruscica et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
EXPERT CONSENSUS DOCUMENT A consensus on the medical treatment of acromegaly
Andrea Giustina et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Effect of Melatonin on Tumor Growth and Angiogenesis in Xenograft Model of Breast Cancer
Bruna Victorasso Jardim-Perassi et al.
PLOS ONE (2014)
The Mechanism of Cytostatic Effect of a New Somatostatin Analog Cifetrelin on In Vitro Cultured MCF-7 Breast Carcinoma Cells
E. I. Mikhaevich et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation
Raffaela Santoro et al.
CARCINOGENESIS (2013)
Molecular mechanisms of melatonin's inhibitory actions on breast cancers
Sara Proietti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
M. Ruscica et al.
CURRENT MOLECULAR MEDICINE (2013)
Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemiareperfusion injury
Hon-Kan Yip et al.
JOURNAL OF PINEAL RESEARCH (2013)
Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma
Karolina Jablonska et al.
JOURNAL OF PINEAL RESEARCH (2013)
Melatonin attenuates dexamethasone toxicity-induced oxidative stress, calpain and caspase activation in human neuroblastoma SH-SY5Y cells
Wilasinee Suwanjang et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation
Emilio J. Sanchez-Barcelo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility
Marta Annunziata et al.
HUMAN REPRODUCTION (2012)
Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations
Carmen Venegas et al.
JOURNAL OF PINEAL RESEARCH (2012)
Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation
R. Santoro et al.
ONCOGENE (2012)
Somatostatin receptor-3 mediated intracellular signaling and apoptosis is regulated by its cytoplasmic terminal
Sajad A. War et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors
Jens Hasskarl et al.
FUTURE ONCOLOGY (2011)
Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model
Brittney Jung-Hynes et al.
JOURNAL OF PINEAL RESEARCH (2011)
Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor
Sara Carbajo-Pescador et al.
JOURNAL OF PINEAL RESEARCH (2011)
Central somatostatin receptor 1 activation reverses acute stress-related alterations of gastric and colonic motor function in mice
A. Stengel et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2011)
Melatonin Induces Apoptotic Cell Death via p53 in LNCaP Cells
Chi Hyun Kim et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2010)
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors
Margarita L. Dubocovich et al.
PHARMACOLOGICAL REVIEWS (2010)
Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer
Seong Soo Joo et al.
JOURNAL OF PINEAL RESEARCH (2009)
Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells
Alessandra Cucina et al.
JOURNAL OF PINEAL RESEARCH (2009)
Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
Tullio Florio
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line
Mari Watanabe et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2008)
Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance
Chun W. Tam et al.
JOURNAL OF PINEAL RESEARCH (2008)
Somatostatin/somatostatin receptor signalling: Phosphotyrosine phosphatases
Tullio Florio
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Novel synergistic mechanism for sst2 somatostatin and TNFα receptors to induce apoptosis:: crosstalk between NF-κB and JNK pathways
J. Guillermet-Guibert et al.
CELL DEATH AND DIFFERENTIATION (2007)
Signaling mechanisms of melatonin in antiproliferation of hormone-refractory 22Rv1 human prostate cancer cells: implications for prostate cancer chemoprevention
Chun W. Tam et al.
JOURNAL OF PINEAL RESEARCH (2007)
Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2
E. Ferrante et al.
ENDOCRINE-RELATED CANCER (2006)
Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients
E Xystrakis et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism
RM Sainz et al.
PROSTATE (2005)
Somatostatin receptors and autoimmune-mediated diabetes
XP Wang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2005)
The basic physiology and pathophysiology of melatonin
B Claustrat et al.
SLEEP MEDICINE REVIEWS (2005)
Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague-Dawley rat
V Lenoir et al.
BREAST CANCER RESEARCH (2005)
Somatostatin analogues: Multiple roles in cellular proliferation, neoplasia, and angiogenesis
P Dasgupta
PHARMACOLOGY & THERAPEUTICS (2004)
Somatostatin receptors in non-endocrine tumours
MC Smith et al.
DIGESTIVE AND LIVER DISEASE (2004)
Anti-migratory and anti-invasive effect of somatostatin in human neuroblastoma cells - Involvement of Rac and MAP kinase activity
S Pola et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells
VASH Dalm et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Melatonin and cell death: differential actions on apoptosis in normal and cancer cells
RM Sainz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Conserved motifs in somatostatin, D2-dopamine, and α2B-adrenergic receptors for inhibiting the Na-H exchanger, NHE1
CY Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Ocular hypotensive effects of melatonin receptor agonists in the rabbit:: further evidence for an MT3 receptor
J Pintor et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis
J Guillermet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Opportunities in somatostatin research: Biological, chemical and therapeutic aspects
G Weckbecker et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis
MZ Strowski et al.
MOLECULAR ENDOCRINOLOGY (2003)
A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors
JC Reubi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Seven-transmembrane receptors
KL Pierce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Somatostatin, acting at receptor subtype 1, inhibits Rho activity, the assembly of actin stress fibers, and cell migration
AMJ Buchan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mammalian melatonin receptors: molecular biology and signal transduction
C von Gall et al.
CELL AND TISSUE RESEARCH (2002)
Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity
A Rimler et al.
PROSTATE (2001)
Peptides as regulators of the immune system: emphasis on somatostatin
S Krantic
PEPTIDES (2000)
Identification of the melatonin-binding site MT3 as the quinone reductase 2
O Nosjean et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2
T Florio et al.
JOURNAL OF PHYSIOLOGY-PARIS (2000)
Melatonin inhibits pituitary adenylyl cyclase-activating polypeptide-induced increase of cyclic AMP accumulation and [Ca2+](i) in cultured cells of neonatal rat pituitary
O Slanar et al.
NEUROCHEMISTRY INTERNATIONAL (2000)
分享论文
